Document is current
Any future updates will be listed below
-
Authors
Frodi, Diana My https://orcid.org/0000-0001-7074-5575
Diederichsen, Søren Zöga https://orcid.org/0000-0002-9687-0857
Xing, Lucas Yixi https://orcid.org/0000-0003-0184-3125
Spona, Daniel Camillo https://orcid.org/0009-0000-2379-6732
Jacobsen, Peter Karl https://orcid.org/0000-0002-1520-8774
Risum, Niels https://orcid.org/0000-0002-0357-9164
Svendsen, Jesper Hastrup https://orcid.org/0000-0001-8466-8515
-
Funding
Funding for this research was provided by:
Eurostars (Eurostars project E!113994- SafeHeart)
Rigshospitalet (The Heart Center Research Fund, Copenhagen University Hospital- Rigshospitalet)
National Hospital
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 9 July 2024
First Online: 21 August 2024
Declarations
:
: Frodi, Xing, Spona, and Risum declare no conflicting interests. Jacobsen has given lectures for Medtronic. Diederichsen is a consultant for Bristol Myers Squibb / Pfizer, Acesion Pharma, Vital Beats and Cortrium. He has received speaker fees from Bristol Myers Squibb / Pfizer and Bayer. Svendsen is a member of an advisory board of Vital Beats and Medtronic and has received speaker’s fee and an unrestricted research grant from Medtronic, independently to this study.
